ginsenoside rh2 has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, M; Liu, Y; Qiao, J; Wang, J; Xing, X; Yin, Y; Yu, S; Zhang, W | 1 |
| Fan, M; Jiang, L; Liu, M; Liu, Y; Qiao, J; Wang, C; Wang, J; Wang, X; Yu, S; Zhang, P; Zhao, D | 1 |
2 other study(ies) available for ginsenoside rh2 and Cancer of Cervix
| Article | Year |
|---|---|
Ginsenoside Rh2 stimulates the production of mitochondrial reactive oxygen species and induces apoptosis of cervical cancer cells by inhibiting mitochondrial electron transfer chain complex.
Topics: Apoptosis; Cell Survival; Female; Ginsenosides; HeLa Cells; Humans; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membranes; Molecular Docking Simulation; Oxidative Phosphorylation; Reactive Oxygen Species; Uterine Cervical Neoplasms | 2021 |
Ginsenoside Rh2 Induces HeLa Apoptosis through Upregulating Endoplasmic Reticulum Stress-Related and Downstream Apoptotic Gene Expression.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Endoplasmic Reticulum Stress; Female; Gene Expression; HeLa Cells; Humans; Molecular Docking Simulation; Uterine Cervical Neoplasms | 2022 |